BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/16/2014 11:44:00 AM | Browse: 1412 | Download: 1892
 |
Received |
|
2012-12-20 12:55 |
 |
Peer-Review Started |
|
2012-12-22 14:30 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2012-12-28 08:46 |
 |
Revised |
|
2013-01-17 12:39 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2013-02-08 09:36 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2013-02-08 11:24 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-04-25 14:40 |
 |
Publish the Manuscript Online |
|
2013-05-07 10:53 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Autobiography |
| Article Title |
Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn's disease patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Kumi Ishida, Takuya Inoue, Kaori Fujiwara, Taisuke Sakanaka, Ken Narabayashi, Sadaharu Nouda, Toshihiko Okada, Kazuki Kakimoto, Takanori Kuramoto, Ken Kawakami, Yosuke Abe, Toshihisa Takeuchi, Mitsuyuki Murano, Satoshi Tokioka, Eiji Umegaki and Kazuhide Higuchi |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Takuya Inoue, MD, PhD, the Second Department of Internal Medicine, Osaka Medical College, 2-7 Daigakumachi, Takatsuki City, Osaka 569-8686, Japan. ureuretakuwan@yahoo.co.jp
|
| Key Words |
Crohn's disease; Adalimumab; Immunomodulator; Azathioprine; Inflammatory bowel disease |
| Core Tip |
In this study, the authors found that adalimumab (ADA) treatment with concomitant azathioprine usage significantly suppressed the Crohn's disease activity index and increased the remission rate at 24 wk after the initiation of therapy, compared with ADA treatment alone.
|
| Publish Date |
2013-05-07 10:53 |
| Citation |
Ishida K, Inoue T, Fujiwara K, Sakanaka T, Narabayashi K, Nouda S, Okada T, Kakimoto K, Kuramoto T, Kawakami K, Abe Y, Takeuchi T, Murano M, Tokioka S, Umegaki E, Higuchi K. Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn’s disease patients. World J Gastroenterol 2013; 19(17): 2676-2682
|
| URL |
http://www.wjgnet.com/1007-9327/full/v19/i17/2676.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v19.i17.2676 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.